Legal & General Group’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.24M | Buy |
935,677
+197,940
| +27% | +$1.74M | ﹤0.01% | 1289 |
|
|
2025
Q1 | $5.52M | Buy |
737,737
+732,436
| +13,817% | +$5.48M | ﹤0.01% | 1480 |
|
|
2024
Q4 | $44.2K | Buy |
5,301
+762
| +17% | +$6.36K | ﹤0.01% | 2803 |
|
|
2024
Q3 | $31.5K | Buy |
4,539
+688
| +18% | +$4.78K | ﹤0.01% | 2881 |
|
|
2024
Q2 | $18.9K | Buy |
3,851
+526
| +16% | +$2.58K | ﹤0.01% | 3043 |
|
|
2024
Q1 | $19.3K | Hold |
3,325
| – | – | ﹤0.01% | 2981 |
|
|
2023
Q4 | $21.8K | Hold |
3,325
| – | – | ﹤0.01% | 2998 |
|
|
2023
Q3 | $16K | Hold |
3,325
| – | – | ﹤0.01% | 3114 |
|
|
2023
Q2 | $17K | Buy |
+3,325
| New | +$17K | ﹤0.01% | 3181 |
|
|
2022
Q2 | – | Sell |
-2,642
| Closed | -$13K | – | 3677 |
|
|
2022
Q1 | $13K | Hold |
2,642
| – | – | ﹤0.01% | 3345 |
|
|
2021
Q4 | $23K | Hold |
2,642
| – | – | ﹤0.01% | 3236 |
|
|
2021
Q3 | $25K | Hold |
2,642
| – | – | ﹤0.01% | 3199 |
|
|
2021
Q2 | $34K | Buy |
+2,642
| New | +$34K | ﹤0.01% | 3093 |
|